Back to Search
Start Over
SQZ Biotechnologies Announces FDA Clearance of Investigational New Drug (IND) Application for SQZ-eAPC-HPV, a Novel mRNA-based Cell Therapy for the Treatment of HPV16 Positive Solid Tumors
- Source :
- Business Wire. January 24, 2022
- Publication Year :
- 2022
-
Abstract
- SQZ[R] Enhanced APCs (eAPCs) Build on Promising Initial SQZ[R] APC Monotherapy Clinical Data by Broadening the Addressable Patient Population and Incorporating Enhanced Immunological Functions to Increase Potency SQZ eAPCs are [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.690295623